Mutated TP53 prevalence in EGFR-mutated advanced non-small cell lung cancer patients with brain metastases

被引：0
|
作者：
Stensgaard, Simone
Eide, Inger Johanne Z.
Stensland, Elin Marie
Helland, Aslaug
Ekman, Simon
Hansen, Karin H.
Cicenas, Saulius
Gronberg, Bjorn Henning
Meldgaard, Peter
Sorensen, Boe S.
Brustugun, Odd Terje
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-2413
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2413
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Prognostic and predictive effects of TP53 mutation in patients with EGFR-mutated non-small cell lung cancer (NSCLC).
    Labbe, Catherine
    Korpanty, Grzegorz
    Tomasini, Pascale
    Doherty, Mark
    Mascaux, Celine
    Jao, Kevin
    Pitcher, Bethany
    Pintilie, Melania
    Leighl, Natasha B.
    Feld, Ronald
    Liu, Geoffrey
    Bradbury, Penelope Ann
    Kamel-Reid, Suzanne
    Tsao, Ming Sound
    Shepherd, Frances A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [2] Progression of leptomeningeal metastases in advanced EGFR-mutated non-small cell lung cancer
    Zhao, Q.
    Deng, L.
    Zhang, Y.
    Zhou, X.
    Li, Y.
    Yu, M.
    Zhou, L.
    Zou, B.
    Liu, Y.
    Lu, Y.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [3] Radiotherapy in brain metastases from EGFR-mutated non-small cell lung cancer
    Bhandari, Shruti
    Dunlap, Neal
    Kloecker, Goetz
    [J]. JOURNAL OF THORACIC DISEASE, 2021, 13 (05) : 3230 - 3234
  • [4] The Management of Brain Metastases in Patients with EGFR Mutated Advanced Non-Small Cell Lung Cancer
    O'Rourke, Noelle
    Gray, Christine M. N.
    Coyte, Aishah
    Featherstone, Carolyn
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S526 - S526
  • [5] TP53 Co-Mutations in Advanced EGFR-Mutated Non-Small Cell Lung Cancer: Prognosis and Therapeutic Strategy for Cancer Therapy
    Liu, Surui
    Yu, Jin
    Zhang, Hui
    Liu, Jie
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [6] Concomitant TP53 Mutation Confers Worse Prognosis in EGFR-Mutated Non-Small Cell Lung Cancer Patients Treated with TKIs
    Canale, Matteo
    Petracci, Elisabetta
    Delmonte, Angelo
    Bronte, Giuseppe
    Chiadini, Elisa
    Ludovini, Vienna
    Dubini, Alessandra
    Papi, Maximilian
    Baglivo, Sara
    De Luigi, Nicoletta
    Verlicchi, Alberto
    Chiari, Rita
    Landi, Lorenza
    Metro, Giulio
    Burgio, Marco Angelo
    Crino, Lucio
    Ulivi, Paola
    [J]. JOURNAL OF CLINICAL MEDICINE, 2020, 9 (04)
  • [7] Prognostic and predictive effects of TP53 co-mutation in patients with EGFR-mutated non-small cell lung cancer (NSCLC)
    Labbe, Catherine
    Cabanero, Michael
    Korpanty, Grzegorz J.
    Tomasini, Pascale
    Doherty, Mark K.
    Mascaux, Celine
    Jao, Kevin
    Pitcher, Bethany
    Wang, Rick
    Pintilie, Melania
    Leighl, Natasha B.
    Feld, Ronald
    Liu, Geoffrey
    Bradbury, Penelope Ann
    Kamel-Reid, Suzanne
    Tsao, Ming-Sound
    Shepherd, Frances A.
    [J]. LUNG CANCER, 2017, 111 : 23 - 29
  • [8] Effectiveness of osimertinib plus chemotherapy and avastin for EGFR-mutated advanced non-small cell lung cancer with brain metastases
    Qin, H.
    Wang, S.
    Gao, F.
    Zeng, Z.
    Liu, X.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S967 - S967
  • [9] Risk factors of metachronous brain metastasis in patients with EGFR-mutated advanced non-small cell lung cancer
    Ouyang, Wen
    Yu, Jing
    Zhou, Yan
    Hu, Jing
    Huang, Zhao
    Zhang, Junhong
    Xie, Conghua
    [J]. BMC CANCER, 2020, 20 (01)
  • [10] Risk factors of metachronous brain metastasis in patients with EGFR-mutated advanced non-small cell lung cancer
    Wen Ouyang
    Jing Yu
    Yan Zhou
    Jing Hu
    Zhao huang
    Junhong Zhang
    Conghua Xie
    [J]. BMC Cancer, 20
12345